医学
淋巴瘤
恶性肿瘤
正电子发射断层摄影术
背景(考古学)
滤泡性淋巴瘤
磁共振成像
放射科
霍奇金淋巴瘤
弥漫性大B细胞淋巴瘤
医学影像学
病理
生物
古生物学
作者
S. Zafar,Rajaei K. Sharma,Joel Cunningham,Preethika Mahalingam,Ayoma D. Attygalle,Nasir Khan,David Cunningham,Dima El‐Sharkawi,Sunil Iyengar,Bhupinder Sharma
标识
DOI:10.1016/j.crad.2020.12.022
摘要
Non-Hodgkin's lymphoma (NHL) encompasses over 40 different haematological malignancies, including low and high-grade neoplasms, such as follicular lymphoma (FL) and diffuse large B-cell lymphoma (DLBCL) respectively. A key clinical issue in the context of NHL is delayed and inaccurate diagnosis, which contributes adversely to patient morbidity and mortality. This article will address relevant imaging aspects, with particular reference to advancements in NHL imaging, including computed tomography (CT), integrated positron-emission tomography (PET)-CT, and magnetic resonance imaging (MRI). We provide multiparametric (anato-functional) imaging display items, including histological correlation. We will also introduce our original concept of "Specialist Integrated Haematological Malignancy Imaging Reporting" (SIHMIR), a paradigm shift in lymphoma radiology. Non-Hodgkin's lymphoma (NHL) encompasses over 40 different haematological malignancies, including low and high-grade neoplasms, such as follicular lymphoma (FL) and diffuse large B-cell lymphoma (DLBCL) respectively. A key clinical issue in the context of NHL is delayed and inaccurate diagnosis, which contributes adversely to patient morbidity and mortality. This article will address relevant imaging aspects, with particular reference to advancements in NHL imaging, including computed tomography (CT), integrated positron-emission tomography (PET)-CT, and magnetic resonance imaging (MRI). We provide multiparametric (anato-functional) imaging display items, including histological correlation. We will also introduce our original concept of "Specialist Integrated Haematological Malignancy Imaging Reporting" (SIHMIR), a paradigm shift in lymphoma radiology.
科研通智能强力驱动
Strongly Powered by AbleSci AI